天弘医药创新C(010655)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
471,678,000 |
459,326,000 |
34,451,400 |
46,803,100 |
-12,351,700 |
-2.62% |
2023/12/31 |
372,884,000 |
471,678,000 |
637,445,000 |
538,651,000 |
98,794,000 |
26.49% |
2023/12/31 |
488,557,000 |
471,678,000 |
58,170,300 |
75,049,000 |
-16,878,700 |
-3.45% |
2023/9/30 |
507,057,000 |
488,557,000 |
91,456,100 |
109,956,000 |
-18,499,900 |
-3.65% |
2023/6/30 |
372,884,000 |
507,057,000 |
487,819,000 |
353,646,000 |
134,173,000 |
35.98% |
2023/6/30 |
568,010,000 |
507,057,000 |
181,204,000 |
242,158,000 |
-60,954,000 |
-10.73% |
2023/3/31 |
372,884,000 |
568,010,000 |
306,614,000 |
111,488,000 |
195,126,000 |
52.33% |
2022/12/31 |
374,346,000 |
372,884,000 |
335,814,000 |
337,276,000 |
-1,462,000 |
-0.39% |
2022/12/31 |
412,729,000 |
372,884,000 |
64,622,700 |
104,468,000 |
-39,845,300 |
-9.65% |
2022/9/30 |
389,157,000 |
412,729,000 |
82,308,700 |
58,736,500 |
23,572,200 |
6.06% |
2022/6/30 |
374,346,000 |
389,157,000 |
188,882,000 |
174,071,000 |
14,811,000 |
3.96% |
2022/6/30 |
386,635,000 |
389,157,000 |
67,306,000 |
64,783,600 |
2,522,400 |
0.65% |
2022/3/31 |
374,346,000 |
386,635,000 |
121,576,000 |
109,288,000 |
12,288,000 |
3.28% |
2021/12/31 |
163,538,000 |
374,346,000 |
862,591,000 |
651,783,000 |
210,808,000 |
128.9% |
2021/12/31 |
284,464,000 |
374,346,000 |
196,226,000 |
106,343,000 |
89,883,000 |
31.6% |
2021/9/30 |
237,612,000 |
284,464,000 |
253,610,000 |
206,758,000 |
46,852,000 |
19.72% |
2021/6/30 |
163,538,000 |
237,612,000 |
412,755,000 |
338,681,000 |
74,074,000 |
45.29% |
2021/6/30 |
192,394,000 |
237,612,000 |
255,757,000 |
210,539,000 |
45,218,000 |
23.5% |
2021/3/31 |
163,538,000 |
192,394,000 |
156,998,000 |
128,142,000 |
28,856,000 |
17.64% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。